ESR1 and cancer: Restoration of expression of genes such as ESR1 [96] or PITX2 [97] sensitizes cancer cells to tamoxifen, and the analysis of promoter methylation status of these genes enables the identification of patients with positive expression of the hormone receptor that will not benefit from the drug administration [62].